Dr. Edward L. Singer, MD

Dr. Singer practices at Gastroenterology Associates in Chula Vista, California.

Dr. Singer's NPI, 1679569743, was assigned on September 23, 2005. Dr. Singer graduated from Joe R. & Teresa Lozano Long School of Medicine in 1972. Dr. Singer's California license number on file is C35550.

Dr. Singer's primary practice is Gastroenterology Associates, at 752 Medical Center Ct Ste 301, Chula Vista, CA 91911-6661. The practice phone is (619) 421-1155.

Dr. Singer's primary practice is Gastroenterology Associates in Chula Vista, California. Dr. Singer is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Singer to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Singer is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Singer's licenses on file in 2 states: California and Texas.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Singer treats.

CMS data shows 789 Medicare services from Dr. Singer across 12 procedure codes in 2024, for 348 Medicare patients. Medicare paid $72,257 for them.

CMS counts 348 Medicare patients who saw Dr. Singer in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 69, with 58% women.

In 2024, Dr. Singer wrote 947 Medicare Part D claims for 212 patients. 89% of them were for generic drugs. CMS names the drug for 668 of them, across 26 drugs with 11 or more claims each, at $49,398 in total drug cost. In 2023, CMS named 823 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Singer for performance year 2024, reported individually. Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singer as offering telehealth. CMS counts 112 procedures of colonoscopy by Dr. Singer, more than 82% of the clinicians it reports for that procedure.

CMS Open Payments shows 128 general payments to Dr. Singer from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $336.

Dr. Singer graduated from Joe R. & Teresa Lozano Long School of Medicine in 1972.

Dr. Singer is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.